Literature DB >> 16951844

[II Brazilian guideline for severe heart disease].

Oscar P Dutra1, Henrique W Besser, Humberto Tridapalli, Tiago Luiz Luz Leiria, Abrahão Afiune Neto, Antonio Felipe Simão, Antonio S Sbissa, Enio Casagrande, Gustavo G de Lima, Iran Castro, Iseu Gus, Ivo A Nesralla, Nelson C de Nonohay, Nestor Daubt, Maria Cláudia Irigoyen, Renato A K Kalil.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16951844     DOI: 10.1590/s0066-782x2006001500024

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  3 in total

1.  Association of the Functional MICA-129 Polymorphism With the Severity of Chronic Chagas Heart Disease.

Authors:  Christiane Maria Ayo; Amanda Priscila de Oliveira; Ana Vitória da Silveira Camargo; Cinara Cássia Brandão de Mattos; Reinaldo Bulgarelli Bestetti; Luiz Carlos de Mattos
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 9.079

2.  Genetic Polymorphisms of IL17 and Chagas Disease in the South and Southeast of Brazil.

Authors:  Pâmela Guimarães Reis; Christiane Maria Ayo; Luiz Carlos de Mattos; Cinara de Cássia Brandão de Mattos; Karina Mayumi Sakita; Amarilis Giaretta de Moraes; Larissa Pires Muller; Julimary Suematsu Aquino; Luciana Conci Macedo; Priscila Saamara Mazini; Ana Maria Sell; Divina Seila de Oliveira Marques; Reinaldo Bulgarelli Bestetti; Jeane Eliete Laguila Visentainer
Journal:  J Immunol Res       Date:  2017-04-02       Impact factor: 4.818

3.  Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.

Authors:  Amanda Priscila de Oliveira; Cássia Rubia Bernardo; Ana Vitória da Silveira Camargo; Luiz Sérgio Ronchi; Aldenis Albaneze Borim; Cinara Cássia Brandão de Mattos; Eumildo de Campos Júnior; Lílian Castiglioni; João Gomes Netinho; Carlos Eugênio Cavasini; Reinaldo Bulgarelli Bestetti; Luiz Carlos de Mattos
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.